Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for BDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 16.81B
March 31, 2026 17.28B
December 31, 2025 19.54B
September 30, 2025 19.88B
June 30, 2025 19.34B
March 31, 2025 19.27B
December 31, 2024 18.76B
September 30, 2024 20.78B
June 30, 2024 19.32B
March 31, 2024 18.01B
December 31, 2023 16.11B
September 30, 2023 16.29B
June 30, 2023 16.78B
March 31, 2023 18.22B
December 31, 2022 16.46B
September 30, 2022 16.45B
June 30, 2022 16.36B
March 31, 2022 18.64B
December 31, 2021 17.42B
September 30, 2021 17.95B
June 30, 2021 15.70B
March 31, 2021 17.72B
December 31, 2020 16.08B
September 30, 2020 18.26B
June 30, 2020 17.43B
Date Value
March 31, 2020 17.15B
December 31, 2019 17.29B
September 30, 2019 19.38B
June 30, 2019 18.02B
March 31, 2019 17.56B
December 31, 2018 17.82B
September 30, 2018 21.48B
June 30, 2018 20.35B
March 31, 2018 22.59B
December 31, 2017 22.10B
September 30, 2017 18.87B
June 30, 2017 18.56B
March 31, 2017 9.082B
December 31, 2016 9.043B
September 30, 2016 11.35B
June 30, 2016 10.56B
March 31, 2016 10.86B
December 31, 2015 10.86B
September 30, 2015 12.12B
June 30, 2015 11.37B
March 31, 2015 12.13B
December 31, 2014 9.94B
September 30, 2014 3.768B
June 30, 2014 3.768B
March 31, 2014 3.764B

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 32.61B
Boston Scientific Corp. 12.62B
Stryker Corp. 15.29B
Baxter International, Inc. 8.857B
Intuitive Surgical, Inc. 0.00